October 2023
1. DREXLER Y, Fornoni A
   Adenine crosses the biomarker bridge: from 'omics to treatment in diabetic kidney disease.
   J Clin Invest. 2023;133:e174015.
   

   >> Share

   
   August 2023
2. SHARMA K, Zhang G, Hansen J, Bjornstad P, et al
   Endogenous adenine mediates kidney injury in diabetic models and predicts diabetic kidney disease in patients.
   J Clin Invest. 2023 Aug 24:e170341. doi: 10.1172/JCI170341.
   

   >> Share

   
   
3. SONG J, Navarro-Garcia JA, Wu J, Saljic A, et al
   Chronic kidney disease promotes atrial fibrillation via inflammasome pathway activation.
   J Clin Invest. 2023 Aug 15:e167517. doi: 10.1172/JCI167517.
   

   >> Share

   
   May 2023
4. SHI T, Burg AR, Caldwell JT, Roskin KM, et al
   Single cell transcriptomic analysis of renal allograft rejection reveals insights into intragraft TCR clonality.
   J Clin Invest. 2023 May 25:e170191. doi: 10.1172/JCI170191.
   

   >> Share

   
   July 2022
5. LI H, Tsokos MG, Tsokos GC
   Lymphocytes in the neighborhood: good or bad for the kidney?
   J Clin Invest. 2022;132.
   

   >> Share

   
   
6. ABRAHAM R, Durkee MS, Ai J, Veselits M, et al
   Specific in situ inflammatory states associate with progression to renal failure in lupus nephritis.
   J Clin Invest. 2022;132.
   

   >> Share

   
   April 2022
7. RABB H, Lee K, Parikh CR
   Beyond kidney dialysis and transplantation: what's on the horizon?
   J Clin Invest. 2022;132.
   

   >> Share

   
   January 2022
8. ATTA MG
   A molecular target of vascular calcification in chronic kidney disease.
   J Clin Invest. 2022;132.
   

   >> Share

   
   November 2021
9. LI W, Feng W, Su X, Luo D, et al
   SIRT6 protects vascular smooth muscle cell from osteogenic transdifferentiation via Runx2 in chronic kidney disease.
   J Clin Invest. 2021 Nov 18. pii: 150051. doi: 10.1172/JCI150051.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share